BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2015
View Archived Issues
Dual GHSR-NPY2R targeting peptides show promise for obesity treatment
Read More
QPCT: new druggable target for Huntington's disease identified by siRNA screen
Read More
Novira Therapeutics divulges anti-HBV azepanes
Read More
Biotest and Affibody sign Albumod research license and option agreement
Read More
Ontario Institute for Cancer Research invests in PanCuRx pancreatic cancer initiative
Read More
HTG Molecular Diagnostics and MD Anderson to investigate molecular diagnostics for lung cancer
Read More
German Centre for Infection Research announces clinical investigation of anti-MRSA
Read More
Phase I results reported for the small-molecule glutaminase inhibitor CB-839
Read More
NeoStem to change name to Caladrius Biosciences
Read More
Vitesse Biologics created by Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development
Read More
ProLynx cleared to start phase I trial of PEG-SN-38
Read More
Oncolytic virus therapy with recombinant HSV-1 is efficient for NSGCT treatment
Read More
EMA provides guidance on MAA submission for Locilex
Read More
Nektar and MD Anderson Cancer Center to collaborate on phase I/II trials of NKTR-214
Read More
Amgen to collaborate with Roche on phase Ib study of talimogene laherparepvec with atezolizumab
Read More
Neovia Oncology and FDA meet to discuss NEV-801 IND
Read More
RaQualia to begin first-in-human phase I study of RQ-00310941
Read More
Wistar Institute patents EBNA-1 inhibitors
Read More
Catabasis Pharmaceuticals discloses PCSK9 inhibitors
Read More
Pfizer presents EGFR inhibitors
Read More
European Commission approves Akynzeo
Read More
NICE recommends Vargatef for NSCLC in England and Wales
Read More
FDA awards orphan drug designation to ibudilast for Krabbe disease
Read More
Amicus submits MAA seeking full European approval of Galafold for Fabry's disease
Read More
FDA issues letter of support for autosomal dominant polycystic kidney disease biomarker
Read More
Genzyme's olipudase alfa granted FDA breakthrough therapy designation
Read More